Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/76335
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSuchiwa Pan-Onen_US
dc.contributor.authorPiyameth Dilokthornsakulen_US
dc.contributor.authorWaree Tiyaboonchaien_US
dc.date.accessioned2022-10-16T07:08:29Z-
dc.date.available2022-10-16T07:08:29Z-
dc.date.issued2022-08-01en_US
dc.identifier.issn18734995en_US
dc.identifier.issn01683659en_US
dc.identifier.other2-s2.0-85131409825en_US
dc.identifier.other10.1016/j.jconrel.2022.05.048en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85131409825&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/76335-
dc.description.abstractAlthough curcumin is globally recognized for its health benefits, its clinical application has been restricted by its poor aqueous solubility and stability. To overcome these limitations, nanocarrier-based drug delivery systems (NDS) are one of the most effective approaches being extensively explored over the last few decades to improve curcumin's physicochemical and pharmacological effects. Various NDS could provide productive platforms for addressing the formulation challenge of curcumin, but evidence of such systems has not been summarized. This study aimed to systematically review current evidence of lipid and polymer-based NDS for an oral delivery of curcumin focusing on in vivo models and clinical studies. Among the 48 included studies, 3 studies were randomized controlled clinical trials, while 45 studies were animal models. To date, only five curcumin NDS have been studied in healthy volunteers: γ-cyclodextrin, phytosome, liposome, microemulsion and solid dispersion, while most curcumin NDS have been studied in animal models. Most included studies found that NDS could increase oral bioavailability of curcumin as compared to free curcumin. In conclusion, this systematic review showed evidence of the positive effect of NDS for enhancement of oral bioavailability of curcumin. Executive summary: Curcumin is globally recognized for its health benefits, but its clinical application has been limited by its poor aqueous solubility and stability, which causes poor absorption in the gastrointestinal tract (GI tract) via oral administration. Nanocarrier-based drug delivery systems (NDS) are considered as a productive platform to solve the formulation challenge of curcumin, but evidence of such systems has not been summarized. This study aimed to systematically review current evidence of lipid and polymer-based NDS for an oral delivery of curcumin focusing on in vivo models and clinical studies. Overall, most studies found that all studied NDS could increase the absorption of curcumin as compared to free curcumin. Curcumin was rapidly absorbed and exhibited a long residence time after oral administration of curcumin NDS. In summary, this systematic review showed positive impacts of NDS for enhancement of oral absorption of curcumin.en_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleTrends in advanced oral drug delivery system for curcumin: A systematic reviewen_US
dc.typeJournalen_US
article.title.sourcetitleJournal of Controlled Releaseen_US
article.volume348en_US
article.stream.affiliationsNaresuan Universityen_US
article.stream.affiliationsThailand Ministry of Educationen_US
article.stream.affiliationsChiang Mai Universityen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.